Please login to the form below

Not currently logged in

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

US insurers can peg access to ICER value reviews

US insurers can peg access to ICER value reviews

The move comes as the drug industry and President Donald Trump have levelled accusations at PBMs and other “middlemen”in the healthcare supply chain of contributing to the problem of high

Latest news

More from news
Approximately 4 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

  • Pharma deals continue to slide Pharma deals continue to slide

    With the dysfunctional political system in the US it is hardly surprising that eight months following President Trump’s inauguration, the repeal of Obamacare has been dropped and the pricing and ... Similarly, the Euro is now around 10% stronger

  • US health reforms US health reforms

    One of the things I think industry is worried about is if Congress and the President can’t get a health bill passed, do they turn to drug pricing because that ... added. President Trump himself has frequently called for lower drug prices. “Once

  • Deal Watch - May 2017 Deal Watch - May 2017

    This analysis includes medtech as well as pharma and biotech. It is speculated that US companies are delaying M&A deals while they wait for President Trump to implement the tax ... In a situation where the Federal Reserve is signalling further increases

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....